MedTrace Logo

A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

NCT06657378 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2025-06-27

No results posted yet for this study

Summary

The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[including secondarily generalized seizures\]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).

Conditions

  • Partial-Onset Seizures
  • Primary Generalized Tonic-clonic Seizures

Interventions

OTHER

No Intervention

This is a non-interventional study.

Sponsors & Collaborators

  • Eisai Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2028-06-15
Completion
2028-06-15

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06657378 on ClinicalTrials.gov